- Komen events raised more than $2 billion to help fund research, education, screening and treatment.
- In 1980, the 5-year relative survival rate for women diagnosed with early-stage breast cancer was about 74 percent. Today, that number is 99 percent.
- Since our founding in 1982, Susan G. Komen’s national research program has invested in cutting-edge research that has helped make major breakthroughs possible.
- Funding for discoveries in genetics and biology has led to personalized, less-invasive breast cancer treatments to replace the less-effective “one-treatment-fits-all” approach.
This is your opportunity to turn your support for the breast cancer movement into action. Prove that you are More Than Pink, and help us end breast cancer forever.